PRESENCE OF BOTH STIMULATING AND BLOCKING TYPES OF TSH-RECEPTOR ANTIBODIES IN SERA FROM 3 PATIENTS WITH PRIMARY HYPOTHYROIDISM

被引：26
|
作者：
KASAGI, K
TAKEDA, K
GOSHI, K
TAKAMATSU, J
HIDAKA, A
HATABU, H
MISAKI, T
IIDA, Y
KUMA, K
KONISHI, J
机构：
[1] KYOTO UNIV, DEPT NUCL MED, KYOTO 606, JAPAN
[2] KUMA HOSP, KOBE, JAPAN
[3] OSAKA MED COLL, DEPT INTERNAL MED, DIV 1, TAKATSUKI, OSAKA 569, JAPAN
[4] HYOGO PREFECTURAL CHILDRENS HOSP, KOBE, JAPAN
来源：
CLINICAL ENDOCRINOLOGY | 1990年 / 32卷 / 02期
关键词：
D O I：
10.1111/j.1365-2265.1990.tb00861.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A case report of three patients with primary hypothyroidism who had potent TSH‐binding inhibitor immunoglobulins (TBII) and both thyroid stimulating (TSAb) and thyroid stimulation‐blocking antibodies (TSBAb) has been described. Two patients displayed symptoms and signs indistinguishable from those in primary myxoedema (cases 1 and 2), and another patient had a history of Graves'disease (case 3). TBII, TSAb and TSBAb activities were 90.0, 1084.2 and 94.5% in case 1, 91.5, 826.6 and 95.8% in case 2, 76.0, 230.0 and 95.0% in case 3, respectively (normal range, < 11.0%, < 145.0 and < 22.0%, respectively. The results indicate that both stimulating and blocking types of TSH‐receptor antibodies exist in these patients. The possible mechanism whereby hypothyroidism developed has been discussed. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码：253 / 260
页数：8
相关论文
共 33 条
  • [21] The Presence of Ganglionic Acetylcholine Receptor Antibodies in Sera from Patients with Functional Gastrointestinal Disorders: A Preliminary Study
    Nakane, Shunya
    Mukaino, Akihiro
    Okumura, Yoshiaki
    Hirosawa, Hiroaki
    Higuchi, Osamu
    Matsuo, Hidenori
    Kainuma, Mosaburo
    Nakatsuji, Yuji
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (05):
  • [22] ASSAYS FOR THYROTROPIN-RECEPTOR BINDING AND THYROID-STIMULATING ANTIBODIES IN SERA FROM PATIENTS WITH GRAVES-DISEASE
    MASSART, C
    HODY, B
    MOUCHEL, L
    EDAN, G
    NICOL, M
    CLINICAL CHEMISTRY, 1986, 32 (07) : 1332 - 1335
  • [23] Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders
    Chen, FQ
    Okamura, K
    Sato, K
    Kuroda, T
    Mizokami, T
    Fujikawa, M
    Tsuji, H
    Okamura, S
    Fujishima, M
    CLINICAL ENDOCRINOLOGY, 1996, 45 (02) : 207 - 214
  • [24] Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from graves' patients
    Osuga, Y
    Liang, SG
    Dallas, JS
    Wang, C
    Hsueh, AJW
    ENDOCRINOLOGY, 1998, 139 (02) : 671 - 676
  • [25] Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease
    Massart, C
    Sonnet, E
    Gibassier, J
    Maugendre, D
    Genetet, B
    CLINICA CHIMICA ACTA, 1997, 265 (02) : 157 - 168
  • [26] Influence of sera and TSH monoclonal antibodies from patients with Graves' disease/ophthalmopathy on growth and differentiation of 3T3-L1 preadipocytes
    Hinata, Takashi
    Watanabe, Yasuhiro
    Morita, Koji
    Kimura, Fumihiko
    Akamizu, Takashi
    Tanaka, Yuji
    ENDOCRINE JOURNAL, 2010, 57 : S465 - S465
  • [27] Growth stimulating antibody, as another predisposing factor of Graves' disease (GD): analysis using monoclonal TSH receptor antibodies derived from patients with GD
    Ihara, Yoshiaki
    Kanda, Yasunari
    Seo, Marie
    Watanabe, Yasuhiro
    Akamizu, Takashi
    Tanaka, Yuji
    ENDOCRINE JOURNAL, 2012, 59 (07) : 571 - 577
  • [28] Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections
    Vazquez, S.
    Cabezas, S.
    Perez, A. B.
    Pupo, M.
    Ruiz, D.
    Calzada, N.
    Bernardo, L.
    Castro, O.
    Gonzalez, D.
    Serrano, T.
    Sanchez, A.
    Guzman, M. G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) : 256 - 262
  • [29] FURTHER CHARACTERIZATION OF A HIGH-AFFINITY THYROTROPIN BINDING-SITE ON THE RAT THYROTROPIN RECEPTOR WHICH IS AN EPITOPE FOR BLOCKING ANTIBODIES FROM IDIOPATHIC MYXEDEMA PATIENTS BUT NOT THYROID STIMULATING ANTIBODIES FROM GRAVES PATIENTS
    KOSUGI, S
    BAN, T
    AKAMIZU, T
    KOHN, LD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) : 1118 - 1124
  • [30] Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients
    Takasu, Nobuyuki
    Matsushita, Mina
    JOURNAL OF THYROID RESEARCH, 2012, 2012
1234